Deal funds clinical development, working capital, corporate purposes
By Devika Patel
Knoxville, Tenn., May 26 – Aldeyra Therapeutics, Inc. said it priced a $12 million public sale of stock with a $1.8 million greenshoe. The offering was announced Wednesday.
The company will sell 2.4 million common shares at $5.00 per share. The price per share is a 10.39% discount to the May 25 closing share price of $5.58.
Stifel is the manager.
Settlement is expected on June 1.
Proceeds will be used for clinical development, clinical trials, debt maintenance, working capital and other general corporate purposes.
The biotechnology company is based in Burlington, Mass.
| Issuer: | Aldeyra Therapeutics, Inc.
|
| Issue: | Common stock
|
| Amount: | $12 million
|
| Greenshoe: | $1.8 million, or 360,000 shares
|
| Shares: | 2.4 million
|
| Price: | $5.00
|
| Warrants: | No
|
| Manager: | Stifel
|
| Announcement date: | May 25
|
| Pricing date: | May 26
|
| Settlement date: | June 1
|
| Stock symbol: | Nasdaq: ALDX
|
| Stock price: | $5.58 at close May 25
|
| Market capitalization: | $50.02 million
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
